Tvardi Therapeutics is trading at $0.88, down 6.43% in live trading on October 26; no clear company-specific announcement explaining the decline was found. - The latest listed company release was an October 14 conference announcement. - Major U.S. indexes were higher, while shares had also closed lower on October 23 and October 22. - No current volume information was available.